Description

2-Benzoyl-6,7,8,9-Tetrahydro-5-Methoxyimidazo[1,2-A]Quinazoline is a high-purity, advanced pharmaceutical intermediate with a complex fused-ring structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly those targeting central nervous system and oncological pathways. It is primarily utilized by research institutions, custom synthesis laboratories, and pharmaceutical manufacturers engaged in the development of new chemical entities and specialty fine chemicals.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of complex drug candidates, especially in medicinal chemistry research.
• Organic Synthesis Building Block: Used in the construction of complex heterocyclic frameworks for novel compound libraries in drug discovery.
• Research & Development (R&D): Serves as a standard or investigational material in academic and industrial research for studying structure-activity relationships (SAR).
• Custom Synthesis: Employed by contract research and manufacturing organizations (CROs/CMOs) for client-specific synthesis projects.
• Chemical Reference Standard: Can be supplied as a high-purity standard for analytical method development and validation in quality control laboratories.

Basic Information

Product Name	2-Benzoyl-6,7,8,9-Tetrahydro-5-Methoxyimidazo[1,2-A]Quinazoline
CAS No.	90807-98-0
Molecular Formula	C19H17N3O2
Molecular Weight	319.36 g/mol
Synonyms	2-Benzoyl-5-methoxy-6,7,8,9-tetrahydroimidazo[1,2-a]quinazoline; Imidazo[1,2-a]quinazoline, 2-benzoyl-6,7,8,9-tetrahydro-5-methoxy-; 5-Methoxy-2-benzoyl-6,7,8,9-tetrahydroimidazo[1,2-a]quinazoline; 90807-98-0; UNII-6V8Q2N8Q1F; 6,7,8,9-Tetrahydro-5-methoxy-2-benzoylimidazo[1,2-a]quinazoline
EINECS	Contact for details

Quality Control

Our 2-Benzoyl-6,7,8,9-Tetrahydro-5-Methoxyimidazo[1,2-A]Quinazoline is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D and synthesis. A comprehensive Certificate of Analysis (COA) detailing purity, assay, and impurity profiles is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.